1. Home
  2. SEE vs CYTK Comparison

SEE vs CYTK Comparison

Compare SEE & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEE
  • CYTK
  • Stock Information
  • Founded
  • SEE 1960
  • CYTK 1997
  • Country
  • SEE United States
  • CYTK United States
  • Employees
  • SEE N/A
  • CYTK N/A
  • Industry
  • SEE Major Chemicals
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEE Industrials
  • CYTK Health Care
  • Exchange
  • SEE Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • SEE 4.6B
  • CYTK 4.6B
  • IPO Year
  • SEE N/A
  • CYTK 2004
  • Fundamental
  • Price
  • SEE $33.93
  • CYTK $51.13
  • Analyst Decision
  • SEE Strong Buy
  • CYTK Buy
  • Analyst Count
  • SEE 10
  • CYTK 15
  • Target Price
  • SEE $38.80
  • CYTK $75.57
  • AVG Volume (30 Days)
  • SEE 1.5M
  • CYTK 2.7M
  • Earning Date
  • SEE 11-06-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • SEE 2.36%
  • CYTK N/A
  • EPS Growth
  • SEE N/A
  • CYTK N/A
  • EPS
  • SEE 1.98
  • CYTK N/A
  • Revenue
  • SEE $5,325,400,000.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • SEE N/A
  • CYTK $330.96
  • Revenue Next Year
  • SEE $1.94
  • CYTK $73.41
  • P/E Ratio
  • SEE $16.68
  • CYTK N/A
  • Revenue Growth
  • SEE N/A
  • CYTK 2635.74
  • 52 Week Low
  • SEE $22.78
  • CYTK $29.31
  • 52 Week High
  • SEE $38.85
  • CYTK $59.39
  • Technical
  • Relative Strength Index (RSI)
  • SEE 66.88
  • CYTK 67.65
  • Support Level
  • SEE $32.66
  • CYTK $50.05
  • Resistance Level
  • SEE $34.11
  • CYTK $53.58
  • Average True Range (ATR)
  • SEE 0.73
  • CYTK 2.55
  • MACD
  • SEE 0.15
  • CYTK 0.94
  • Stochastic Oscillator
  • SEE 88.66
  • CYTK 83.74

About SEE Sealed Air Corporation

Sealed Air is organized via two reporting segments. Food includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Protective includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: